CHEOY CochLear Ltd ADR

USD 103.45 -1.34 -1.278748
Icon

CochLear Ltd ADR (CHEOY) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 103.45

-1.34 (-1.28)%

USD 13.71B

3.00K

N/A

N/A

Icon

CHEOY

CochLear Ltd ADR (USD)
COMMON STOCK | OTC
USD 103.45
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 13.71B

N/A

USD 103.45

CochLear Ltd ADR (CHEOY) Stock Forecast

N/A

Based on the CochLear Ltd ADR stock forecast from 0 analysts, the average analyst target price for CochLear Ltd ADR is not available over the next 12 months. CochLear Ltd ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CochLear Ltd ADR is Slightly Bullish , which is based on 9 positive signals and 5 negative signals. At the last closing, CochLear Ltd ADR’s stock price was USD 103.45. CochLear Ltd ADR’s stock price has changed by +0.81% over the past week, -4.68% over the past month and +23.33% over the last year.

No recent analyst target price found for CochLear Ltd ADR
No recent average analyst rating found for CochLear Ltd ADR

Company Overview CochLear Ltd ADR

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, ...Read More

https://www.cochlear.com

1 University Avenue, Sydney, NSW, Australia, 2109

4,800

June

USD

USA

Adjusted Closing Price for CochLear Ltd ADR (CHEOY)

Loading...

Unadjusted Closing Price for CochLear Ltd ADR (CHEOY)

Loading...

Share Trading Volume for CochLear Ltd ADR Shares

Loading...

Compare Performance of CochLear Ltd ADR Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CHEOY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To CochLear Ltd ADR (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SMMNY
Siemens Healthineers AG ADR +0.25 (+0.90%) USD67.12B 40.46 16.99

ETFs Containing CHEOY

Symbol Name CHEOY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About CochLear Ltd ADR (CHEOY) Stock

Stock Target Advisor's fundamental analysis for CochLear Ltd ADR's stock is Slightly Bullish .

CHEOY stock's dividend yield is 1.16%. Our analysis grades CHEOY stock's dividend yield at F. This means that CHEOY stock's dividend yield is above 36% of the stocks in the Medical Devices sector in the OTC exchange. Based on this CHEOY may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on CHEOY's stock to indicate what its average analyst target is.

CHEOY stock's Price/Earning ratio is 60.10. Our analysis grades CHEOY stock's Price / Earning ratio at F. This means that CHEOY stock's Price/Earning ratio is above 72% of the stocks in the Medical Devices sector in the OTC exchange. Based on this CHEOY may be a overvalued for its sector.

The last closing price of CHEOY's stock was USD 103.45.

The most recent market capitalization for CHEOY is USD 13.71B.

Unfortunately we do not have enough analyst data on CHEOY's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains CochLear Ltd ADR's stock.

As per our most recent records CochLear Ltd ADR has 4,800 Employees.

CochLear Ltd ADR's registered address is 1 University Avenue, Sydney, NSW, Australia, 2109. You can get more information about it from CochLear Ltd ADR's website at https://www.cochlear.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...